Wedbush Securities’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History

Wedbush Securities’s Portfolio CNCR Stock Details CNCR Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell
2021 Q3	$202K	Sell
2021 Q2	$230K	Sell
2021 Q1	$241K	Buy
2020 Q4	$204K	Buy